Prudential Financial’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$225K	Buy	+17,530	New	+$223K	﹤0.01%	2105
2025 Q4	–	Sell	-13,294	Closed	-$230K	–	2364
2025 Q3	$230K	Sell	13,294 -145	-1%	-$1.79K	﹤0.01%	2183
2025 Q2	$158K	Buy	+13,439	New	+$110K	﹤0.01%	2246
2024 Q3	–	Sell	-23,739	Closed	-$531K	–	2772
2024 Q2	$531K	Buy	23,739 +298	+1%	+$7.09K	﹤0.01%	2161
2024 Q1	$645K	Buy	23,441 +15,632	+200%	+$434K	﹤0.01%	2058
2023 Q4	$238K	Buy	7,809 +125	+2%	+$3.59K	﹤0.01%	2389
2023 Q3	$243K	Buy	7,684 +499	+7%	+$19.4K	﹤0.01%	2332
2023 Q2	$293K	Buy	7,185 +568	+9%	+$23K	﹤0.01%	2304
2023 Q1	$357K	Sell	6,617 -115	-2%	-$4.51K	﹤0.01%	2218
2022 Q4	$235K	Buy	6,732 +204	+3%	+$9.7K	﹤0.01%	2353
2022 Q3	$361K	Buy	6,528 +141	+2%	+$8.75K	﹤0.01%	2217
2022 Q2	$335K	Sell	6,387 -16,568	-72%	-$841K	﹤0.01%	2299
2022 Q1	$1.67M	Sell	22,955 -68,927	-75%	-$5.84M	﹤0.01%	1614
2021 Q4	$11M	Buy	91,882 +25,060	+38%	+$3.14M	0.01%	700
2021 Q3	$9.11M	Sell	66,822 -374	-0.6%	-$56.6K	0.01%	762
2021 Q2	$10.9M	Buy	67,196 +9,792	+17%	+$762K	0.01%	735
2021 Q1	$4.61M	Buy	57,404 +52,470	+1,063%	+$3.52M	0.01%	1064
2020 Q4	$269K	Buy	+4,934	New	+$179K	﹤0.01%	2277